UPDATE

EMF Disturbance Monitors, Inc. is negotiating with our university collaborator to complete the FDA Phase II and FDA Phase III trials for a cardiac application of our patented technology.

SAVING LIVES BY SAVING TIME

EMF Disturbance Monitors has developed a novel medical device platform that measures the strength of the electromagnetic energy field created by organs such as the heart and the brain.

Many human diseases are caused by decreased cellular energy production such as congestive heart failure, cardiomyopathy, traumatic brain injury (TBI), severe depression and dementia. These diseases can be difficult to diagnose using current technology. This can result in a delay in diagnosis that results in irreversible loss of heart or brain cells.

Our solution is an outpatient test that is brief and non-invasive. Early diagnosis of diseases improves patient outcome. We hope to revolutionize the screening process for many diseases that result from low cellular energy production.